Moderna

Implementation Science Liaison

United States

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Public Health, Medical ResearchIndustries

Implementation Science Lead (ISL)

Employment Type: Full time

Position Overview

The Implementation Science Lead (ISL) is a field-based role responsible for leading regional implementation projects, knowledge dissemination, and integration initiatives aimed at improving patient outcomes and public health management. The ISL will build peer-to-peer relationships and identify new partnership opportunities with regional experts within Integrated Delivery Networks (IDNs) and academic medical centers. This role involves working with diverse professional teams to assess gaps and unmet medical needs, lead collaborative studies, develop evidence-based educational programs, and evaluate the impact of these interventions on patient outcomes and public health objectives. Day-to-day activities include protocol development, analysis, publications, and dissemination programs focused on bridging the gap between research and practice and supporting the application of evidence-based interventions to impact regional public health management.

Responsibilities

  • Develop and maintain relationships with Key Opinion Leaders (KOLs) at IDNs and local academic medical centers.
  • Maintain expertise across relevant disease areas and the regional landscape, including specialties involved in patient care, scientific gaps, delivery barriers, and local healthcare systems contributing to understanding patient health management.
  • Identify clinical care gaps and unmet medical needs at the IDN level.
  • Generate tailored, system-specific strategic plans based on evidence-to-practice gaps and tactic plans, including strategic engagements and projects.
  • Manage and execute measurable implementation projects, such as behavioral studies, Real-World Evidence (RWE) research, and patient health management/educational programs that address pre-identified clinical care gaps.
  • Lead collaborative programs to disseminate and support the broad integration of evidence-based interventions.
  • Collaborate with all field-based partners, including Medical Affairs colleagues and commercial teams, while maintaining full compliance with requirements.
  • Collaborate with US teams on scientific insight gathering to support the scientific communication narrative and contribute to medical affairs strategy and scientific engagement plans.

Requirements (Basic Qualifications)

  • Minimum of MSc and/or MPH.
  • Minimum of 4 years of experience in a field-based role in the global pharmaceutical industry with a demonstrated successful track record.
  • Minimum of 3 years of research experience, including concept and protocol development, data analysis, and a proven publication record.
  • Strong communication, interpersonal, and presentation skills.

Qualifications (Preferred Qualifications)

  • Advanced scientific degree preferred – MD, Ph.D., PharmD.
  • Prior vaccines/infectious diseases experience.
  • Strong business acumen and excellent understanding of the US healthcare environment.
  • Candidates will ideally have well-established networks, familiarity with local healthcare systems, and an understanding of decision-making structures at the regional level.
  • Passion for narrowing the gap between research and practice by implementing customized evidence-based interventions.
  • Ability to identify opportunities and unmet medical needs and to take ownership of finding creative and innovative solutions.
  • Extensive experience leveraging data and insights to inform strategies and optimize plans.
  • Proven ability to take the initiative, determine priorities, lead, and execute.
  • Self-motivation with a track record of excelling in a fast-paced work environment.
  • Acceptance of challenges with curiosity and drive while remaining positive in the face of obstacles.
  • Strong understanding of compliance frameworks and ability to work compliantly in a field-based role within the medical organization, as well as interacting with the commercial organization.
  • A desire to make an impact as part of a high-growth, transformational company that is Bold, Relentless, Curious, and Collaborative.

Skills

Implementation Projects
Knowledge Dissemination
Partnership Development
Clinical Care Gaps Analysis
Real-World Evidence (RWE) Research
Patient Education Program Development
Protocol Development
Data Analysis
Scientific Publication
Stakeholder Engagement
Healthcare Systems Understanding

Moderna

Develops mRNA-based medicines for health

About Moderna

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a crucial component in how cells produce proteins necessary for biological functions. Their approach involves creating a new class of medicines that utilize mRNA to instruct cells to produce specific proteins, potentially leading to significant advancements in treating diseases. Unlike traditional pharmaceuticals, which often rely on chemical compounds, Moderna's mRNA-based therapies aim to enhance the discovery, development, and manufacturing processes of medicines. The company's goal is to improve patient outcomes by harnessing the power of mRNA to create effective treatments.

Cambridge, MassachusettsHeadquarters
2010Year Founded
$5,925.5MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
5,001-10,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Paid Vacation
Paid Sick Leave
Paid Holidays
Sabbatical Leave
Hybrid Work Options
401(k) Company Match
Parental Leave
Family Planning Benefits
Fertility Treatment Support
Adoption Assistance
Wellness Program
Mental Health Support
Phone/Internet Stipend
Home Office Stipend

Risks

Potential backlash in Australia for bypassing vaccine safety steps.
Possible removal from Nasdaq 100 Index could affect investor confidence.
Hong Kong residents' reluctance to get vaccinated may hinder market penetration.

Differentiation

Moderna is pioneering mRNA technology for new categories of medicines.
The company integrates AI to optimize mRNA design and production processes.
Moderna's mRNA platform enables rapid development of vaccines and therapeutics.

Upsides

Moderna received a $176 million contract for a bird flu vaccine.
The company is expanding mRNA applications to personalized cancer vaccines.
Moderna is establishing a domestic mRNA production facility in Australia.

Land your dream remote job 3x faster with AI